knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 23:45:45 - browse：12

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Listen: Vivek Ramaswamy's star turn & leaky drug data

Wikipedia

WSS

Why Sanofi got shellacked over its spinoff

Diversifying clinical trials isn't enough to close racial gaps: study

How the first Native Hawaiian psychiatrist helped diversify medicine

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Intellia plays down concerns on accidental germline transmission

Testing for cancer recurrence creates a new limbo for patients

hotspot

knowledge

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

First Opinion Podcast: How to protect health care in times of war

New air purifier tech could be key to improving indoor air quality

Eli Lilly to pay $200M for Beam’s stake in gene

How one medical school became remarkably diverse

Vivek Ramaswamy made waves in the debate, much as in biotech

Jerome Adams on the need for new antivirals for Covid

Testing for cancer recurrence creates a new limbo for patients

BioMarin wins approval for gene therapy to treat hemophilia A

FDA has safety concerns on CRISPR

leisure time

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Trans patients at the end of life deserve respect and dignity

Meta's Zuckerberg and Chan on track to put $50 billion into science

Trans patients at the end of life deserve respect and dignity

Can U.S. cancer drug shortages be fixed?

Eli Lilly to pay $200M for Beam’s stake in gene

focus

Wikipedia

Wikipedia

leisure time